Note: Axonics Modulation Technology's revenues are gauged from an analysis of company filings.
Axonics Modulation Technology's Income Statement (based on Industry Averages)
Axonics Modulation Technology P&L
$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
Investor Activity
Axonics Modulation Technology has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.
Date
Investors
Percent Raised
Target Size
April 12, 2018
17
100%
$55 MM
Complete list of funding rounds and total amounts in the Company Report
Trademark Applications
Trademark applications show the products and services that Axonics Modulation Technology is developing and marketing.
Axonics Modulation Technology doesn't have any recent trademark applications, indicating Axonics Modulation Technology is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
AXONICS R-SNM SYSTEM Nerve stimulator apparatus, namely, an external implantable pulse generator and internal implantable neurological lead for neurostimulation, as well as a charging system comprised primarily of a battery charger, patient remote control and physician programmer in the nature of downloadable communication software pre-programed by the manufacturer and downloadable control software pre-programed by the manufacturer that allows for direct communication between the patient and the system and/or the clinician and the system in order to configure or regulate the stimulation parameters for the implanted portion of the system, all sold together as a unit along with related system components comprised of surgical instrumentation, batteries, device display monitors, device display microprocessors, battery chargers and downloadable software pre-programed by the manufacturer for operating and programming the nerve stimulator apparatus
05/29/2020
R-SNM Nerve stimulator apparatus, namely, an external implantable pulse generator and internal implantable neurological lead for neurostimulation, as well as a charging system comprised primarily of a battery charger, patient remote control and physician programmer in the nature of communication software and control software that allows for direct communication between the patient and the system and/or the clinician and the system in order to configure or regulate the stimulation parameters for the implanted portion of the system, all sold together as a unit along with related system components comprised of surgical instrumentation, batteries, device display monitors, device display microprocessors, battery chargers and software for operating and programming the nerve stimulator apparatus
03/02/2017
AXONICS SNM SYSTEM Nerve stimulator apparatus, namely, an external implantable pulse generator and internal implantable neurological lead for neurostimulation, as well as a charging system comprised primarily of a battery charger, patient remote control and physician programmer in the nature of communication software and control software that allows for direct communication between the patient and the system and/or the clinician and the system in order to configure or regulate the stimulation parameters for the implanted portion of the system, all sold together as a unit along with related system components comprised of surgical instrumentation, batteries, device display monitors, device display microprocessors, battery chargers and software for operating and programming the nerve stimulator apparatus
02/03/2017
See all trademarks and details in the Full Report.
Market Share of Axonics Modulation Technology's Largest Competitors
A competitive analysis shows these companies are in the same general field as Axonics Modulation Technology, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Axonics Modulation Technology.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Axonics Modulation Technology and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.
My Watch List
